Response to comments on the Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL‐cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Supporting Publications ◽

10.2903/sp.efsa.2012.en-333 ◽

2012 ◽

Vol 9 (9) ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Ldl Cholesterol ◽

Health Claim ◽

Plant Stanols ◽

Plant Stanol ◽

Scientific Opinion ◽

Plant Stanol Esters ◽

Download Full-text

Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal ◽

10.2903/j.efsa.2012.2692 ◽

2012 ◽

Vol 10 (5) ◽

pp. 2692 ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Ldl Cholesterol ◽

Health Claim ◽

Plant Stanols ◽

Plant Stanol ◽

Scientific Opinion ◽

Plant Stanol Esters ◽

Download Full-text

Plant stanol esters and blood cholesterol ‐ Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

EFSA Journal ◽

10.2903/j.efsa.2008.825 ◽

2008 ◽

Vol 6 (10) ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Blood Cholesterol ◽

Health Claim ◽

Plant Stanol ◽

Scientific Opinion ◽

Scientific Substantiation ◽

Plant Stanol Esters ◽

Download Full-text

Response to comments on the Scientific Opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL‐cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006

EFSA Supporting Publications ◽

10.2903/sp.efsa.2012.en-332 ◽

2012 ◽

Vol 9 (9) ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Ldl Cholesterol ◽

Plant Sterols ◽

Health Claim ◽

Scientific Opinion ◽

Download Full-text

Scientific Opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006

EFSA Journal ◽

10.2903/j.efsa.2012.2693 ◽

2012 ◽

Vol 10 (5) ◽

pp. 2693 ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Ldl Cholesterol ◽

Plant Sterols ◽

Health Claim ◽

Scientific Opinion ◽

Download Full-text

Scientific Opinion on the substantiation of a health claim related to the consumption of 2 g/day of plant stanols (as plant stanol esters) as part of a diet low in saturated fat and a two-fold greater reduction in blood LDL-cholesterol concentrations comp

EFSA Journal ◽

10.2903/j.efsa.2013.3160 ◽

2013 ◽

Vol 11 (4) ◽

pp. 3160

Author(s):

Keyword(s):

Ldl Cholesterol ◽

Saturated Fat ◽

Health Claim ◽

Plant Stanols ◽

Plant Stanol ◽

Scientific Opinion ◽

Plant Stanol Esters

Download Full-text

Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the modification of the authorisation of a health claim related to plant sterol esters and lowering blood LDL‐cholesterol; high blood LDL‐cholesterol is a risk factor in the development of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006, following a request in accordance with Article 19 of Regulation (EC) No 1924/2006

EFSA Supporting Publications ◽

10.2903/sp.efsa.2014.en-596 ◽

2014 ◽

Vol 11 (5) ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Risk Factor ◽

Heart Disease ◽

Plant Sterol ◽

Ldl Cholesterol ◽

Health Claim ◽

Sterol Esters ◽

Scientific Opinion

Download Full-text

Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal ◽

10.2903/j.efsa.2011.2471 ◽

2011 ◽

Vol 9 (12) ◽

pp. 2471 ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Blood Cholesterol ◽

Health Claim ◽

Beta Glucans ◽

Scientific Opinion ◽

Download Full-text

Achievement of LDL cholesterol goal with addition of plant stanol esters to diets of coronary heart disease (CHD) patients on statin therapy

Atherosclerosis Supplements ◽

10.1016/s1567-5688(02)80096-4 ◽

2002 ◽

Vol 3 (2) ◽

pp. 85

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Statin Therapy ◽

Ldl Cholesterol ◽

Plant Stanol ◽

Cholesterol Goal ◽

Plant Stanol Esters

Download Full-text

Scientific Opinion on the modification of the authorisation of a health claim related to plant sterol esters and lowering blood LDL-cholesterol; high blood LDL-cholesterol is a risk factor in the development of (coronary) heart disease pursuant to Article

EFSA Journal ◽

10.2903/j.efsa.2014.3577 ◽

2014 ◽

Vol 12 (2) ◽

pp. 3577 ◽

Author(s):

Keyword(s):

Coronary Heart Disease ◽

Risk Factor ◽

Heart Disease ◽

Plant Sterol ◽

Ldl Cholesterol ◽

Health Claim ◽

Sterol Esters ◽

Scientific Opinion

Download Full-text

Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of health claims related to consumption of 2 g/day of plant stanols (as plant stanol esters) as part of a diet low in saturated fat and a two‐fold greater reduction in blood LDL‐cholesterol concentrations compared to the consumption of a diet low in saturated fat alone pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Supporting Publications ◽

10.2903/sp.efsa.2013.en-507 ◽

2013 ◽

Vol 10 (11) ◽

Author(s):

Keyword(s):

Ldl Cholesterol ◽

Saturated Fat ◽

Health Claims ◽

Plant Stanols ◽

Plant Stanol ◽

Scientific Opinion ◽

Scientific Substantiation ◽

Plant Stanol Esters

Download Full-text